Using engineered exosomes to help regenerate bone
Bioprinting of MSC Exosomes for Bone Regeneration
['FUNDING_R03'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-10437003
This study is exploring a new way to help bones heal better by using tiny particles from stem cells, which are placed in a special gel that can be shaped into helpful structures for bone repair, and if it works, it could really benefit patients needing bone healing.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-10437003 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new method to enhance bone regeneration using exosomes derived from mesenchymal stem cells (MSCs). The approach involves encapsulating these engineered exosomes in a special hydrogel that can be 3D printed to create scaffolds for bone repair. By optimizing the delivery and release of these exosomes, the research aims to improve their effectiveness in promoting bone healing. Patients may benefit from this innovative technique if it proves successful in clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with bone injuries or conditions that impair bone healing.
Not a fit: Patients with stable bone conditions that do not require regeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced treatments for patients with bone injuries or conditions requiring regeneration.
How similar studies have performed: Previous research has shown promise in using engineered exosomes for tissue regeneration, indicating potential success for this novel approach.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HUANG, CHUN-CHIEH — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: HUANG, CHUN-CHIEH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.